- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
A new function for drug combination dose finding trials ; volume:14 ; number:1 ; day:12 ; month:2 ; year:2024 ; pages:1-8 ; date:12.2024
Scientific reports ; 14, Heft 1 (12.2.2024), 1-8, 12.2024
- Creator
-
Xiao, Jiacheng
Zhang, Weijia
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-53155-4
- URN
-
urn:nbn:de:101:1-2404220835296.520303886888
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Xiao, Jiacheng
- Zhang, Weijia
- SpringerLink (Online service)
Other Objects (12)
A clinical phase I dose-finding design with adaptive shrinking boundaries for drug combination trials
A multiple comparison procedure for dose‐finding trials with subpopulations
Too bad! Fixed dose combination antiretroviral drugs
Dose-finding studies in drug development for rare genetic diseases
Optimal designs for active controlled dose finding trials with efficacy-toxicity outcomes
Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice
Subgroup analyses and investigations of treatment effect heterogeneity in clinical dose-finding trials
Dose‐finding methods for Phase I clinical trials using pharmacokinetics in small populations
A dose-finding design for phase I clinical trials based on Bayesian stochastic approximation
An adaptive gBOIN design with shrinkage boundaries for phase I dose-finding trials
Biases affecting injected doses of an experimental drug during clinical trials
Biocombinatorial approaches for drug finding
A clinical phase I dose-finding design with adaptive shrinking boundaries for drug combination trials
A multiple comparison procedure for dose‐finding trials with subpopulations
Too bad! Fixed dose combination antiretroviral drugs
Dose-finding studies in drug development for rare genetic diseases
Optimal designs for active controlled dose finding trials with efficacy-toxicity outcomes
Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice
Subgroup analyses and investigations of treatment effect heterogeneity in clinical dose-finding trials
Dose‐finding methods for Phase I clinical trials using pharmacokinetics in small populations
A dose-finding design for phase I clinical trials based on Bayesian stochastic approximation
An adaptive gBOIN design with shrinkage boundaries for phase I dose-finding trials
Biases affecting injected doses of an experimental drug during clinical trials
Biocombinatorial approaches for drug finding
A clinical phase I dose-finding design with adaptive shrinking boundaries for drug combination trials
A multiple comparison procedure for dose‐finding trials with subpopulations
Too bad! Fixed dose combination antiretroviral drugs
Dose-finding studies in drug development for rare genetic diseases
Optimal designs for active controlled dose finding trials with efficacy-toxicity outcomes
Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice
Subgroup analyses and investigations of treatment effect heterogeneity in clinical dose-finding trials
Dose‐finding methods for Phase I clinical trials using pharmacokinetics in small populations
A dose-finding design for phase I clinical trials based on Bayesian stochastic approximation
An adaptive gBOIN design with shrinkage boundaries for phase I dose-finding trials
Biases affecting injected doses of an experimental drug during clinical trials